Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

150.74
Delayed Data
As of Apr 29
 -2.94 / -1.91%
Today’s Change
89.76
Today|||52-Week Range
314.88
+0.93%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues1.4M445.0K445.0K447.0K
 
 
 
 
 
Depreciation And Amortization250.4K395.6K413.0K632.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses40.9M48.9M51.8M88.7M
 
 
 
 
 
Research And Development28.0M28.3M27.5M44.4M
 
 
 
 
 
Total Operating Expenses41.1M49.3M52.2M89.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-39.7M-48.8M-51.8M-88.9M
 
 
 
 
 
Other Expenses271.9K930.0K889.0K637.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-39.4M-47.9M-50.9M-88.3M
 
 
 
 
 
Net Income-39.4M-47.9M-50.9M-88.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS22.2M24.0M24.2M24.4M
 
 
 
 
 
Shares To Calculate EPS Diluted22.2M24.0M24.2M24.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.78-$1.99-$2.10-$3.62
 
 
 
 
 
EPS Diluted-$1.78-$1.99-$2.10-$3.62